Valneva: presentations planned at conferences

(CercleFinance.com) - Valneva announces that members of its management team will make presentations and participate in meetings with institutional investors at upcoming conferences, in Boston on November 12, and London on November 19.


At these presentations, CEO Thomas Lingelbach and CFO Peter Bühler will review the company's key value drivers and expected catalysts, which include various clinical results in 2025.

Among the most notable results will be the key Phase 3 results for its Lyme disease vaccine candidate, for which Pfizer plans to submit regulatory submissions in Europe and the USA in 2026.

Copyright (c) 2024 CercleFinance.com. All rights reserved.